About Riva Therapeutics
Riva Therapeutics is a Healthcare company based in San Diego (United States) founded in 2022 by Brion W Murray. Small molecule therapeutics targeting cancer cell processes are developed. Riva Therapeutics offers products and services including Small Molecule Therapeutics. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its competitors include Moderna, BeiGene and Incyte; 2 of its 3 listed competitors have raised funding.
Company details
Riva Therapeutics was founded in 2022 in San Diego, United States. Small molecule therapeutics for oncology are developed by the company. Focus is placed on creating treatments that selectively target essential processes in tumor cells, extending beyond DNA damage repair mechanisms. Operations center on advancing these therapeutics through research and development in the biotechnology sector.
- Headquarters San Diego, United States
- Founders Brion W Murray
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website rivatherapeutics.com
- Social LinkedIn
- Investors
Products & Services of Riva Therapeutics
Riva Therapeutics offers a comprehensive portfolio of products and services, including Small Molecule Therapeutics.
Therapies targeting tumor cell processes for effective cancer treatment.
Funding Insights of Riva Therapeutics
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Riva Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Riva Therapeutics
Riva Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark |
Investor details for Riva Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Riva Therapeutics
3 people are tracked at Riva Therapeutics (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Brion W Murray | Co-Founder | Leadership |
John Farnam | Chief Operating Officer | Leadership |
Carolyn Coglianese | Executive Assistant / Office Manager | Team |
Complete people profiles for Riva Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Riva Therapeutics
2 dated milestones of Riva Therapeutics, from founding to its latest funding, stage changes and deals.
- Founded Riva Therapeutics is founded.
- Funding First funding round.
Competitors of Riva Therapeutics
Riva Therapeutics has 3 listed competitors in our database, 2 of them funded. They include Moderna, BeiGene and Incyte.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| incyte.com | 1991 | Wilmington, United States | 1,387 | Small molecules are developed for cancer and skin disease treatments. |
Detailed competitors of Riva Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Riva Therapeutics (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Riva Therapeutics
Riva Therapeutics was founded in 2022.
Riva Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Riva Therapeutics was founded in 2022 in San Diego, United States. Small molecule therapeutics for oncology are developed by the company. Focus is placed on creating treatments that selectively target essential processes in tumor cells, extending beyond DNA damage repair mechanisms. Operations center on advancing these therapeutics through research and development in the biotechnology sector.
Riva Therapeutics offers Small Molecule Therapeutics.
Riva Therapeutics has 1 investor. Key investors include Novo Holdings.